COMBINED ANALYSIS WITH BCL-2 AND P53 IMMUNOSTAINING PREDICTS POORER PROGNOSIS IN PROSTATIC CARCINOMA
- 1 December 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 158 (6) , 2278-2283
- https://doi.org/10.1016/s0022-5347(01)68235-1
Abstract
Purpose: The objective of the current study is to investigate the relationship between bcl-2 and p53 expression and prognosis in prostatic carcinoma.Materials and Methods: One hundred and f...Keywords
This publication has 18 references indexed in Scilit:
- Prognostic Value of Bcl-2 and p53 Expression in Urinary Tract Transitional Cell CancerJNCI Journal of the National Cancer Institute, 1996
- Relationship of p53 and bcl-2 to Prognosis in Muscle-Invasive Transitional Cell Carcinoma of the BladderJournal of Urology, 1996
- bcl‐2 Expression in Prostate Cancer and its Relationship to Cell Cycle and PrognosisInternational Journal of Urology, 1996
- bcl-2: Role in epithelial differentiation and oncogenesisHuman Pathology, 1996
- p53 Mutations Occur in Clinical, but Not Latent, Human Prostate CarcinomaJapanese Journal of Cancer Research, 1995
- Bcl‐2 protein expression in carcinomas originating from the follicular epithelium of the thyroid glandThe Journal of Pathology, 1994
- Frequency and characterization of p53 mutations in primary and metastatic human prostate cancerInternational Journal of Cancer, 1994
- Small Subgroup of Aggressive, Highly Proliferative Prostatic Carcinomas Defined by p53 AccumulationJNCI Journal of the National Cancer Institute, 1992
- Nucleotide sequence of a t(14;18) chromosomal breakpoint in follicular lymphoma and demonstration of a breakpoint-cluster region near a transcriptionally active locus on chromosome 18.Proceedings of the National Academy of Sciences, 1985
- The t(14;18) Chromosome Translocations Involved in B-Cell Neoplasms Result from Mistakes in VDJ JoiningScience, 1985